A Phase II Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of A Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection (CDI)
收藏DataCite Commons2026-03-16 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007664/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Primary objective: To compare the event rate of CDI in groups assigned to ACAM-CDIFF™ vaccine
versus placebo in the 9 week period after the third dose of the study vaccine in subjects
with first episode of CDI receiving antibiotics standard of care.
Secondary objective: To evaluate the safety of all dose groups of ACAM-CDIFF™ vaccine versus
placebo in subjects with first episode of CDI receiving antibiotics standard of care.
提供机构：
Vivli
创建时间：
2022-02-08
